Since the 1980s, hundreds of Israeli companies have listed on the Nasdaq or NYSE and 99 are currently listed. Israel has led all other countries in foreign companies listed on these exchanges, apart from China and Canada. U.S.-listed Israeli companies span all industries, but fast-growing and innovative technology and life sciences companies are particularly well represented and have found great success in the U.S. capital markets.
The U.S. capital markets offer excellent opportunities for tech and life sciences startups to raise the necessary capital to achieve growth and scale. A listing on a U.S. exchange allows Israeli companies to access deep pools of capital from institutional and retail investors and attract investment from both U.S. and global investors. A NYSE or Nasdaq listing provides liquidity, visibility, and credibility to a company, often leading to further opportunities for strategic partnerships, acquisitions, and brand recognition.
Additionally, the U.S. market tends to offer higher valuations for innovative tech and life sciences companies, compared to many other regions of the world. As a result, Israeli companies may achieve better valuations, which can help them raise more capital at favorable terms. The advantages of a U.S. listing can help Israeli companies accelerate growth, benefit their founders and early investors and expand their global reach.
Click here to view the full article